Bristol-Myers Squibb Company (BMY)
Debt-to-equity ratio
| Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | ||
|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 18,473,000 | 16,335,000 | 29,430,000 | 31,061,000 | 35,946,000 |
| Debt-to-equity ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2025 calculation
Debt-to-equity ratio = Long-term debt ÷ Total stockholders’ equity
= $—K ÷ $18,473,000K
= 0.00
Peer comparison
Dec 31, 2025
Company name
Symbol
Debt-to-equity ratio
Bristol-Myers Squibb Company
BMY
0.00
AbbVie Inc
ABBV
—
Amgen Inc
AMGN
0.00
Biogen Inc
BIIB
0.00
Eli Lilly and Company
LLY
0.00
Gilead Sciences Inc
GILD
—
Johnson & Johnson
JNJ
0.00
Merck & Company Inc
MRK
0.00
Organon & Co
OGN
0.00
Pfizer Inc
PFE
0.00